1. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration 
Alasdair Reid, MD, Fabio Scano, MD, Haileyesus Getahun, MD, Brian Williams, PhD, Christopher Dye, DPhil, Paul Nunn, FRCP, Kevin M De Cock, MD, Catherine Hankins, FRCP, Bess Miller, MD, Kenneth G Castro, MD, Dr Mario C Raviglione, MD 
The Lancet Infectious Diseases 
Volume 6, Issue 8, Pages (August 2006)
DOI: /S (06)
Copyright © 2006 Elsevier Ltd Terms and Conditions

2. Figure 1 Estimated incidence of all forms of tuberculosis in 20048
The Lancet Infectious Diseases 2006 6, DOI: ( /S (06) )
Copyright © 2006 Elsevier Ltd Terms and Conditions

3. Figure 2
Estimated prevalence of HIV in adults aged 15–49 years in 20049
The Lancet Infectious Diseases 2006 6, DOI: ( /S (06) )
Copyright © 2006 Elsevier Ltd Terms and Conditions

4. Figure 3
Relation between incidence of infectious tuberculosis (2002)8 and adult HIV prevalence in
The slope of the line is 13 cases per 100 000 population for each 1% increase in HIV prevalence.
The Lancet Infectious Diseases 2006 6, DOI: ( /S (06) )
Copyright © 2006 Elsevier Ltd Terms and Conditions

5. Figure 4
Time trends in the estimated prevalence of HIV in adults in Zimbabwe9 and notification rates of all forms of tuberculosis8
The Lancet Infectious Diseases 2006 6, DOI: ( /S (06) )
Copyright © 2006 Elsevier Ltd Terms and Conditions

6. Figure 5
Relation between the proportion of notified tuberculosis patients that are women and the prevalence of HIV in adults aged 15–49 years8
The Lancet Infectious Diseases 2006 6, DOI: ( /S (06) )
Copyright © 2006 Elsevier Ltd Terms and Conditions